Litcius/Paper detail

Efficient antitumor effects of a novel oncolytic adenovirus fully composed of species B adenovirus serotype 35

Ryosuke Ono, Kosuke Takayama, Fuminori Sakurai, Hiroyuki Mizuguchi

2021Molecular Therapy — Oncolytics28 citationsDOIOpen Access PDF

Abstract

tumor cell lysis activities in the presence of anti-Ad5 and naive serum. OAd35 significantly suppressed growth of the subcutaneous CAR-positive and CAR-negative tumors following intratumoral administration. These results indicated that OAd35 is a promising alternative oncolytic virus for OAd5.

Topics & Concepts

Oncolytic virusOncolytic adenovirusCoxsackievirusVirologyBiologySerotypeAntibodyVirusCell cultureAdenoviridaeCancer researchImmunologyGenetic enhancementGeneEnterovirusBiochemistryGeneticsVirus-based gene therapy researchCAR-T cell therapy researchViral Infectious Diseases and Gene Expression in Insects
Efficient antitumor effects of a novel oncolytic adenovirus fully composed of species B adenovirus serotype 35 | Litcius